Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
November 2012
Features
Editorial
Reinventing the Pharmacy and Therapeutics Committee
As value-based reimbursement and accountable-care models drive us into an era of cost-containment and care-management strategies, the P&T committee must reinvent itself.
David Shulkin, MD
Health Care & Law
Accountable Care Organizations
An Improvement Over HMOs?
The ACO model is considered an important achievement of health care reform legislation. However, ACOs might not be able to deliver on their promises in part because of the slowly recovering economy. It is also not clear how much money will be saved, and not all hospitals plan to participate.
Rita M. Marcoux, RPh, MBA; E. Paul Larrat, RPh, PhD; and F. Randy Vogenberg, RPh, PhD
The Nanomedicine Revolution
Part 3: Regulatory and Safety Challenges
Before the FDA can set up safety guidelines for nanomedicines, it needs to establish valid testing criteria. The goal is to strike a balance between underregulation (which can lead to questionable approvals) and overregulation (which can inhibit innovation).
C. Lee Ventola, MS
Implementation of Management Guidelines For Chronic Myeloid Leukemia
Perspectives in the United States
Twenty percent to 30% of CML patients are not being treated according to clinical practice guidelines. The authors review the most recent guidelines published by the National Comprehensive Cancer Network and the European LeukemiaNet.
David Rizzieri, MD; and Joseph O. Moore, MD
Departments
Medication Errors
Beware of Basal Opioid Infusions With Patient-Controlled Analgesia
Basal opioid infusions may raise the risk of respiratory depression when given with patient-controlled analgesia.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Pharmacists Hope to Bill Under New Medicare ‘G’ Code
Payment Would Be for Transitional Care After Hospital Discharge
A new Medicare ‘G’ code for transitional care may help to reduce the number of hospital readmissions.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Pharmaceutical Approval Update
Bosutinib (Bosulif) tablets for chronic myelogenous leukemia; linaclotide (Linzess) for irritable bowel syndrome/constipation and chronic idiopathic constipation; and regorafenib (Stivarga) tablets for metastatic colorectal cancer
Marvin M. Goldenberg, PhD, RPh, MS
